Kirstine Frantz

Kirstine Frantz (Jacobsen) is an accomplished professional with extensive experience in biologics development and project management. Currently serving as a Senior Project Manager for CMC Biologics at ProtaGene since November 2022, Kirstine oversees biologics development programs, managing project scope, quality, timelines, risks, and budgets, while focusing on continuous improvement. Previously, Kirstine held various roles at Novo Nordisk from June 2016 to November 2022, including Research Scientist in Injectable Formulation Development, where contributions were made to the development of semaglutide and cagri-sema, and led projects on stability studies and the implementation of paperless laboratory systems. With a solid educational background, including a PhD in oncology and large-scale protein analysis from the University of Southern Denmark, Kirstine also has experience in teaching and research at several academic institutions.